Summit Therapeutics
SMMT
#2244
Rank
C$11.41 B
Marketcap
C$14.27
Share price
-5.87%
Change (1 day)
-37.50%
Change (1 year)

EPS for Summit Therapeutics (SMMT)

EPS in 2026 (TTM): C-$1.50

According to Summit Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$1.53. In 2025 the company made an earnings per share (EPS) of C-$2.08.

EPS history for Summit Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.50-27.93%
2025C-$2.08
2021C-$1.3826.32%
2020C-$1.09
2018C-$0.06225-84.63%
2017C-$0.40-40.59%
2016C-$0.686.54%
2015C-$0.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sarepta Therapeutics
SRPT
C-$3.77 145.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
C$19.88-1,395.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
C-$1.48-3.74%๐Ÿ‡บ๐Ÿ‡ธ USA